“Cheryl brings significant commercial expertise to Tokai. As the former Chief Commercial Officer of Medivation, Cheryl led the company’s highly successful launch of Xtandi® in the United States and built the company’s commercial infrastructure from the ground up,” said Jodie Morrison, President and Chief Executive Officer of Tokai Pharmaceuticals. “As we make final preparations to start ARMOR3-SV and begin our commercialization planning for galeterone, Cheryl’s first-hand experience marketing Xtandi, as well as her broader expertise in oncology and new drug commercialization, should provide immediate contributions to Tokai and its Board of Directors. It is my pleasure to welcome Cheryl to the Tokai Board.”
My guess is that they will be partnering with MDVN or MDVN will put in a buyout offer.
Im sticking around for the 1.5 years to see what happens. Bought in around 12 awhile back and I believe the PPS will be around $30 BEFORE phase III results are announced.
You seriously think it is employee selling a measly 8500 shares as bad new is coming out? You really think they would risk their job and worse yet being jailed for insider trading the this amount of money? Come on you have to be smarter than that. My bet is just the opposite, good news is coming and he/she is trying to manipulate the price lower to scoop all the cheap shares possible.
Sentiment: Strong Buy
If you took my advice and bought at the open this morning you would be up about 15%. Still going much higher in my opinion.
As of today I am invested in PTN and feel this company will be very successful. Another company which has a very high probability of a multi-bagger is TKAI. This company is very under the radar and will most likely triple from todays PPS even before results from their stage 3 trial are announced late next year/early 2017. The Seeking Alpha article "Tokai Pharmaceuticals: The Small Cap Biotech With The Billion Dollar Prostate Cancer Drug" pretty much sums it up. Good luck and happy investing.
Havent been on the board much but I see the usual crew is still here. Bigs flipping back and forth between bashing and then pumping SSH the following day. Ex trying to convince everyone and himself that he is an important individual which is hard for him to do with his broken english. I have been out of SSH for a few months now but definitely still follow and will once again re-invest in SSH down the road. One company with much shorter road to blockbuster success is TKAI. This company is very under the radar and will most likely triple from todays PPS even before results from their stage 3 trial are announced late next year/early 2017. The Seeking Alpha article "Tokai Pharmaceuticals: The Small Cap Biotech With The Billion Dollar Prostate Cancer Drug" pretty much sums it up. Good luck and happy investing.